Latest filing published 20 Aug 2026 for Eton Pharmaceuticals, Inc., €5.5M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Brynjelsen Sean appears in our data through filings on Eton Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 2 filings, all for trades on 19 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 20 August 2026, reports a transaction of €5.5M in Eton Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations